Oral, patch, gel or local
Hormone Therapy
From $79/mo
- Personalized symptom support
- Provider-selected format
- Ongoing follow-up
Get startedVytal programs
Read program safety information
Treatment requires provider approval. Start with an approximately 3-minute intake.
Describe the symptoms affecting your day-to-day life, how long they have been present and your health history. A provider can consider hormonal and non-hormonal pathways in the context of your individual needs.
Personalized hormonal and non-hormonal options for perimenopause and menopause symptoms, selected after a clinical review.

Oral, patch, gel or local
From $79/mo
Prescription pill
From $79/mo
Systemic + local
Personalized
Pricing reflects the current program structure and may vary by formulation, dose and subscription. Available in all 50 states. Prescription treatment requires clinical approval.
Have your medication list, relevant medical history and questions ready. Ask the clinical team whether labs or an in-person visit are needed. Program information is educational and is not a diagnosis or a treatment recommendation.
Agile Telehealth is our partner for doctors and pharmacy services and handles patient billing. Existing patients can use the patient hub for treatment and account questions.
No. The program includes hormonal and non-hormonal pathways. Your provider determines whether an option is appropriate after reviewing your symptoms and history.
Listed formats include oral, patch, gel and local options. Ask about the risks and expected benefits of the exact formulation, and how the follow-up plan will assess whether it is helping.
The displayed “from” price is a starting price, not a final quote for every plan. Confirm the selected treatment, recurring billing, follow-up and any separate costs with Agile Telehealth.
Treatment safety and important limitations
Possible effects of menopausal hormone medicines include breast tenderness, headache, nausea and spotting. Serious risks depend on the product, route, age, medical history and timing of treatment; they can include blood clots, stroke and certain cancers. These risks are not identical for all hormonal and non-hormonal options.
Systemic estrogen without an appropriate progestogen can increase endometrial-cancer risk in someone who has a uterus. Tell your provider about unexplained vaginal bleeding, a history of hormone-sensitive cancer, blood clots, stroke or liver disease, and any possibility of pregnancy.
FDA has updated warnings for some menopause products. Review the current label for your exact treatment with your clinician rather than assuming every product has the same warning. Non-hormonal medicines also have their own risks and monitoring needs.
Sources: FDA menopause medicine information and updated prescribing information.
Educational overview, updated October 2, 2026. This is not a complete list of risks or a substitute for your provider’s instructions. For a medical emergency, call 911.